Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
Phillips
Elizabeth
E
Hayden
Anna
A
Gutiérrez
Sonia
S
Jahnke
Natalie
N
Yip
Benita
B
Lima
Viviane D
VD
Hogg
Robert S
RS
Harrigan
P Richard
PR
Montaner
Julio S G
JS
D019380:Anti-HIV Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D015658:HIV Infections / Q000401:mortality; D019698:Hepatitis C, Chronic / Q000401:mortality; D006801:Humans; D019829:Nevirapine / Q000009:adverse effects*
D019380:Anti-HIV Agents; D019829:Nevirapine